Jump to content
Main menu
Main menu
move to sidebar
hide
Navigation
Main page
Recent changes
Random page
Help about MediaWiki
Special pages
Niidae Wiki
Search
Search
Appearance
Create account
Log in
Personal tools
Create account
Log in
Pages for logged out editors
learn more
Contributions
Talk
Editing
Anthrax
(section)
Page
Discussion
English
Read
Edit
View history
Tools
Tools
move to sidebar
hide
Actions
Read
Edit
View history
General
What links here
Related changes
Page information
Appearance
move to sidebar
hide
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
=== Biologic for Drug-, Antibody- or Vaccine-resistant Anthrax === Treatment of multi-drug resistant, antibody- or vaccine-resistant Anthrax is also possible. Legler, et al.<ref>{{cite journal | vauthors = Legler PM, Little SF, Senft J, Schokman R, Carra JH, Compton JR, Chabot D, Tobery S, Fetterer DP, Siegel JB, Baker D, Friedlander AM | title = Treatment of experimental anthrax with pegylated circularly permuted capsule depolymerase | journal = Science Translational Medicine | volume = 13 | issue = 623 | pages = eabh1682 | date = December 2021 | pmid = 34878819 | doi = 10.1126/scitranslmed.abh1682 }}</ref> showed that pegylated CapD (capsule depolymerase) could provide protection against 5 LD50 exposures to lethal Ames spores without the use of antibiotics, monoclonal antibodies, or vaccines. The CapD enzyme removes the poly-D-glutamate (PDGA) capsular material from the bacteria, rendering it susceptible to the innate immune responses. The unencapsulated bacteria can then be cleared.<ref>{{YouTube|id=QVSM2vaTFaE|title=Engineered enzyme against antibiotic resistant anthrax}}</ref> [[File:CapD.jpg|thumb|center|400px|''B. anthracis'' Capsule Depolymerase (CapD) degrades the unusual PDGA capsule on the outer surface of the bacterium. The pegylated enzyme has been used in mice to protect against five LD50 challenges of lethal Ames spores.<ref name="pmid22257032">{{cite journal | vauthors = Hu X, Legler PM, Khavrutskii I, Scorpio A, Compton JR, Robertson KL, Friedlander AM, Wallqvist A | title = Probing the donor and acceptor substrate specificity of the Ξ³-glutamyl transpeptidase | journal = Biochemistry | volume = 51 | issue = 6 | pages = 1199β1212 | date = February 2012 | pmid = 22257032 | doi = 10.1021/bi200987b }}</ref> The human enzyme (white surface) has been overlaid onto the bacterial CapD structure (PDB 3G9K,<ref name="Joachimiak">{{cite journal | vauthors = Wu R, Richter S, Zhang RG, Anderson VJ, Missiakas D, Joachimiak A | title = Crystal structure of Bacillus anthracis transpeptidase enzyme CapD | journal = The Journal of Biological Chemistry | volume = 284 | issue = 36 | pages = 24406β24414 | date = September 2009 | pmid = 19535342 | pmc = 2782033 | doi = 10.1074/jbc.M109.019034 | doi-access = free }}</ref> blue ribbon). In red is the substrate binding loop of HuGGT which CapD lacks. CapD binds polymers of D-glutamate. Original figure from Hu, Legler, et al.<ref name="pmid22257032" />]]
Summary:
Please note that all contributions to Niidae Wiki may be edited, altered, or removed by other contributors. If you do not want your writing to be edited mercilessly, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource (see
Encyclopedia:Copyrights
for details).
Do not submit copyrighted work without permission!
Cancel
Editing help
(opens in new window)
Search
Search
Editing
Anthrax
(section)
Add topic